Mueller-Eckhardt C, Mersch-Baumert K
Vox Sang. 1977 Oct;33(4):221-33. doi: 10.1111/j.1423-0410.1977.tb04467.x.
To assess two modifications of the platelet factor 3 (PF3) test for platelet antibody detection, an analysis of test conditions was performed with normal test material (serum, plasma, globulin fraction), defined HLA-specific, complement-fixing antisera and a quinidine-induced antiserum. It was shown that, under standardized conditions, the PF3 test revealed known platelet antibodies confirming earlier results. Its reproducibility and, to a lesser degree, its sensitivity were inferior to platelet complement fixation. In contrast, the test did not permit the reliable determination of platelet autoantibodies in sera of 89 thrombocytopenic patients including 36 cases of idiopathic thrombocytopenic purpura. Positive results loosely corresponded to the presence of HLA antibodies in sera.
为评估用于检测血小板抗体的血小板因子3(PF3)试验的两种改良方法,使用正常试验材料(血清、血浆、球蛋白组分)、明确的HLA特异性补体结合抗血清和奎尼丁诱导的抗血清进行了试验条件分析。结果表明,在标准化条件下,PF3试验可检测出已知的血小板抗体,证实了早期的结果。其重复性以及在较小程度上其敏感性均低于血小板补体结合试验。相比之下,该试验无法可靠地测定89例血小板减少症患者血清中的血小板自身抗体,其中包括36例特发性血小板减少性紫癜患者。阳性结果大致与血清中HLA抗体的存在情况相符。